<DOC>
	<DOCNO>NCT00246155</DOCNO>
	<brief_summary>The purpose study analyse change back muscle size strength follow use DysportÂ® , establish whether association pain reduction change strength , patient suffer chronic low back pain .</brief_summary>
	<brief_title>Study Effects Botulinum Toxin Type A Back Muscle Chronic Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Suffering muscular low back pain ( L1 S1 level ) . Symptoms six month duration . No benefit previous treatment . Patient must present bilaterally 2 active trigger point ( TrPs ) region low back musculature . CT scan MRI examination lumbar spine perform within past year . Absence significant pathology , bone fracture , nerve damage severe psychiatric condition . Constant persistent severe pain due nerve root compression fibromyalgia . The patient receive surgery spine . Other musculoskeletal disability e.g . myasthenia gravis , disorder neuromuscular junction . Any serious pathology , cancer , systemic inflammatory disease , vertebral fracture , neurological sign , spinal infection . Epidural injection local anaesthetic steroid within 12 week proceed inclusion . Trigger point injection local anaesthetic steroid within 8 week proceed inclusion . Pain associate urinary tract infection , gynaecological disorder . Bleeding disturbance currently use coumarin derivative .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>chronic</keyword>
	<keyword>muscular</keyword>
</DOC>